Introduction
Nonalcoholic fatty liver disease (NAFLD) is regarded as the most common chronic liver disease in the Western world and incidence have increased worldwide over recent decades. NAFLD is characterized by fat accumulation within the liver and can be classified into two types: 1) simple steatosis and 2) nonalcoholic steatohepatitis (NASH). Both types are associated with obesity, insulin resistance, metabolic syndrome and type II diabetes. While simple steatosis is considered a benign condition, NASH is associated with inflammation and hepatocyte damage and can often lead to fibrosis, cirrhosis, and liver cancer if not diagnosed and treated at early stages. It is currently unknown why some people develop one form over the other. To date, there are no approved medicines to treat either condition, and diet modification and weight control are the current recommended treatments. The CCN family of matricellular proteins consists of six members (CCN1-CCN6) (Yeger and Perbal 2007) . The family name originates from the common names of the first three proteins characterized (cysteine-rich 61 (CYR61) -CCN1 / connective tissue growth factor (CTGF) -CCN2 / nephroblastoma overexpressed (NOV) -CCN3). CCN3 is associated with many cardiovascular processes; ranging from neovascular development in utero and angiogenesis (Klenotic et al. 2016) , to mitigation of aortic aneurysm formation and atherosclerotic plaque development (Liu et al. 2014; Zhang et al. 2016; Shi et al. 2017) . Interestingly, it was found that CCN3 originated within the myeloid compartment was critical for mitigation of vascular disease progression. CCN3 also plays a role in osteoblast differentiation (Ouellet and Siegel 2012) , obesity, insulin resistance and diabetes (Martinerie et al. 2016; Escote et al. 2017) , and tumor development (Barreto et al. 2016; Yeger and Perbal 2016) . Less is known about the role of CCN3 within the liver. Borkham-Kamphorst et al., has shown that CCN3 expression increased significantly at the mRNA and protein levels in models of experimental hepatic fibrosis (BorkhamKamphorst et al. 2012b ), yet overexpression of CCN3 fails to mitigate liver fibrogenesis, in part, due to enhanced reaction oxygen species production and cytokine signaling, which lead to the induction of hepatocyte injury and apoptosis (BorkhamKamphorst et al. 2016) . Since the absence of myeloid-derived CCN3 has previously been shown to exacerbate cardiovascular disease, it was of great interest to determine whether CCN3's protective effects also translate to the liver in the context of NASH progression.
Materials and methods

LysM
Cre/Cre mice were commercially available from Jackson Laboratory (Farmington, CT). CCN3 flox/flox mice were generated by Ozgene (Cambridge, MA) by insertion of LoxP sites that flank exon 2 of the CCN3 gene. The result of the crossing yielded LysM Cre/Cre
CCN3
flox/flox mice which were used in the experiments described below, with LysM
Cre/Cre mice used as control animals. All animal genotypes were verified by PCR. Mice were fed either a methionine-and choline-deficient (MCD) diet (MP Biomedicals, Santa Ana, CA) or normal chow (CHOW) for 8 weeks. All animal protocols were approved by the Institutional Animal Care and Use Committee at Case Western Reserve University, which is certified by the American Association of Accreditation for Laboratory Animal Care.
Plasma ALT and AST and liver triglycerides
Plasma alanine aminotransferase (ALT) and plasma aspartate aminotransferase (AST) assay kits were purchased from Sekisui Diagnostics (Lexington, MA) and the protocol provided by the manufacturer was followed.
Lipid analysis
Measurements of liver tissue triglyceride, cholesterol and cholesterol ester levels were performed by the Vanderbilt NIH Mouse Metabolic Phenotyping Core. CCN3 flox/flox mice probed for SREBP-1. f qPCR analysis of Peroxisome proliferator-activated receptor alpha (PPAR-α), Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1), and carnitine palmitoyltransferase I (L-CPT-1) levels. g qPCR analysis of Peroxisome proliferator-activated receptor gamma (PPAR-γ) and cluster of differentiation 36 (CD36) levels. Scale bars = 200 μm. In all graphs, LysM cre/cre is depicted with black bars and LysM cre/cre CCN3 flox/flox is depicted with grey bars. *P < 0.05, **P < 0.01, #P < 0.001
RNA isolation and qPCR
Total RNA from mouse liver tissue was isolated using Aurum™ Total RNA Fatty and Fibrous Tissue Kit (BioRad, Hercules, CA). cDNA was synthesized from 1 μg mRNA template using iScript Reverse Transcriptase (BioRad) and subjected to qPCR with SYBR green Real-Time PCR Master Mix (Applied Biosystems, Waltham, MA) on a QuantStudio 6 Flex real-time PCR System (Applied Biosystems). Gene expression was normalized to β-actin using the ΔΔCt method of calculation.
Protein isolation and western blot analysis
Protein was extracted from tissues using RIPA buffer (SigmaAldrich, St. Louis, MO) supplemented with proteinase and phosphatase inhibitors (Roche Diagnostics, Indianapolis, IN). Protein concentrations were determined using a bicinchoninic acid (BCA) protein assay kit (Pierce Biotechnology, Waltham, MA). Western blots of liver were performed following standard protocols. SREBP-1 antibody was from BD Biosciences (San Jose, CA). CHOP, XBP-1 and mouse β-actin antibodies were from Santa Cruz Biotechnology (Dallas, TX). Phospho-RIP3 antibody was from Abcam (Cambridge, MA). Liver histological and immunohistochemical analysis Livers were fixed in 10% phosphate-buffered formalin acetate at 4°C overnight and embedded in paraffin wax. Paraffinembedded serial sections (7 μm) were cut and mounted onto glass slides for hematoxylin and eosin staining and for assessment of F4/80 (Santa Cruz), MCP-1 (Santa Cruz) and CD45 (Santa Cruz). Paraffin-embedded sections were also used for Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) using the DNA Fragmentation Assay Kit from Clontech Laboratories, (Mountain View, CA). Staining for Oil Red O (Alfa Aesar, Haverhill, MA) and Dihydroethidium (DHE) (Invitrogen, Carlsbad, CA) was performed on sections cut from frozen liver embedded in OCT. Nuclei were labeled using Vectashield with DAPI (Vector Laboratories, Burlingame, CA) or hematoxylin.
Statistics
All values are reported as means ± standard error of the mean (SEM), n = 4 chow-fed and n = 7 for MCD-fed mice. To analyze the difference between 2 groups, the Student's t test was used. A P value less than 0.05 was considered significant.
Results
CCN3 protects against NASH progression
We employed the Cre-lox recombination system to delete CCN3 from myeloid cells to test its importance in the progression of NASH. LysM flox/flox mice (grey bars) showed significant increases in triglycerides (TG), total cholesterol (T Chol) and cholesterol ester (CE) concentrations, all markers of fatty acid disease, when compared to the LysM cre/cre control group (black bars) (Fig. 1a) . No difference between the two groups was observed when fed a normal CHOW diet (Fig. 1a) . Enhanced lipid accumulation was observed in liver tissue harvested from LysM To gain insight into how the loss of myeloid CCN3 results in increased lipid accumulation within the liver, qPCR was performed to assess the levels of key genes involved in lipid synthesis (Fig. 1d) . SREBP-1, FASN, ELOVL-6, ACC, and SCD-1 all were significantly increased at the messenger level in LysM cre/cre CCN3 flox/flox mice on the MCD diet (Fig. 1d , grey bars) when compared to the LysM cre/cre control group (Fig. 1d, black bars) . SREBP-1 is also shown to be significantly increased at the protein level (Fig. 1e) . Concurrently, LysM cre/cre CCN3 flox/flox mice on the MCD diet, when compared to control, had decreased levels of PPAR-α, PGC-1 and L-CPT-1, genes important for lipid oxidation (Fig. 1f) , while both PPAR-γ and CD36, genes critical for oxidized lipoprotein uptake into cells, were significantly increased (Fig. 1g) . Taken together, these data show that CCN3 affects several pathways involved in lipid regulation, and the loss of myeloid CCN3 results in increased lipid accumulation within the liver.
Loss of myeloid-derived CCN3 leads to an increased inflammatory state To further assess the increase in NASH severity due to myeloid CCN3 ablation, LysM cre/cre and LysM cre/cre
CCN3
flox/flox mice were tested for alanine transaminase (ALT) and aspartate transaminase (AST) levels in plasma. These two transaminases are well known biomarkers for overall liver health, and increased concentrations of one or both are indicative of liver disease. Plasma samples from mice on normal chow showed very low ALT and AST levels (Fig. 2a) . On the MCD diet, both control LysM cre/cre mice, and myeloid-deficient CCN3 LysM cre/cre CCN3 flox/flox mice showed elevated ALT and AST amounts as expected. Without myeloid-derived CCN3 present, however, the ALT and AST levels are markedly, and significantly increased, approximately double that of the control group (compare LysM cre/cre , MCD, with that of LysM cre/cre CCN3 flox/flox , MCD, Fig. 2a) . Concomitantly, increased inflammatory cytokines were elevated in the MCD diet groups (Fig. 2b) . While both IL-6 and IL-10 were unchanged between LysM (Fig. 2c) , hematopoietic marker CD45 (Fig. 2d) , and cytokine MCP-1 (Fig. 2e) . Collectively, increases in biomarkers, tissue cytokines and inflammatory cells suggest an increased inflammatory state in liver from mice lacking myeloid-derived CCN3.
Loss of myeloid-derived CCN3 contributes to increased stress signals within the liver Both endoplasmic reticulum (ER) and oxidative stress contribute to overall tissue health and homeostasis. During onset of NASH, an influx of cytokines and inflammatory cells can severely increase stress signals within the liver. To assess the effect of the myeloid deficiency of CCN3 on ER stress, protein levels of two transcription factors important in the ER stress response, C/EBP homologous protein (CHOP) and X-box binding protein 1 (XBP-1) were analyzed. On the MCD diet, LysM cre/ cre CCN3 flox/flox mice had from moderately (XBP-1) to significantly (CHOP) higher protein levels in liver tissue when compared to the LysM cre/cre mice control group (Fig. 3a) . This was recapitulated in qPCR results (Fig. 3b) along with an increase in nuclear factor (erythroid-derived 2)-like 2 (Nrf2), a regulator of proteins that protect the tissue from oxidative damage (Fig. 3b, right panel) . Additional evidence of increased oxidative stress in liver tissue from LysM cre/ cre CCN3 flox/flox mice is shown in Fig. 3c . When treated with dihydroethidium (DHE), LysM cre/cre CCN3 flox/flox tissue shows an intense staining when compared to controls (Fig. 3c, lower right panel) , suggesting the presence of increased reactive oxygen species (ROS). These data show that the absence of myeloid-derived CCN3 contributes to increased severity of NASH, in part, by increased ER and oxidative stress within the liver.
Myeloid CCN3-deficiency causes increased programmed cell death in NASH-induced liver disease A downstream effect in tissue with aberrant inflammatory cell deposition and oxidative stress signals is an increase in programmed cell death. A TUNEL assay in Fig. 4a shows an increase in apoptosis within LysM cre/cre CCN3 flox/flox tissue from mice that were on a MCD diet when compared to the LysM cre/cre mice control group. Necroptosis is also induced in LysM is depicted with grey bars. *P < 0.05, **P < 0.01, #P < 0.001 interacting serine/threonine-protein kinase 1 (RIPK1) and receptor-interacting serine/threonine-protein kinase 3 (RIPK3) expression (Fig. 4b) , with increases in p-RIPK3 verified at the protein level (Fig. 4c) . Therefore, myeloid CCN3 deficiency leads to increased NASH severity, in part, due to increased apoptosis and necroptosis within the liver. 
flox/flox mice fed either normal chow or MCD diet. b qPCR analysis of receptor-interacting serine/threonine-protein kinase 1 (RIPK1) and receptor-interacting serine/threonine-protein kinase 3 (RIPK3) levels from liver tissue of the same groups as described in A. c Western blot of p-RIPK3 from liver tissue as described in A. Scale bar = 200 μm. In all graphs, LysM cre/cre is depicted with black bars and LysM cre/cre CCN3 flox/flox is depicted with grey bars. *P < 0.05, **P < 0.01, #P < 0.001 the loss of CCN3 within myeloid cells upon aortic aneurysm development ) and atherosclerosis (Shi et al. 2017) . Bone marrow (BM) transplantation of ApoE −/− ; CCN3 −/− BM into lethally irradiated ApoE −/− recipient mice significantly exacerbated atherosclerotic plaque development while the reciprocal experiment greatly reduced the severity of the induced phenotype. This highlighted the importance of non-tissue-derived CCN3 (instead of resident CCN3 produced in endothelial cells and smooth muscle cells for example) in the development of vascular diseases. Since myeloidderived CCN3 can be ubiquitously transported to other tissue through the circulatory system, and CCN3 has been shown to effect liver homeostasis, it was of great interest to determine whether its protective effects also translate to the liver, where fat deposition and ensuing disease progression and complications in many ways mimic those seen in the vasculature. Mice, deficient in CCN3 within myeloid cells, were fed a methionine-and choline-deficient diet to induce NASH. Indeed, in mice lacking myeloid-derived CCN3, there was increased fat deposition within the liver, concomitant with increased immune cell infiltration, reactive oxygen species generation and programmed cell death, all physiological events associated with NASH (Fig. 5) . This is consistent with the results seen in aortic tissue upon aneurysm development ) and in our atherosclerotic mouse model (Shi et al. 2017) .
At the molecular level, loss of myeloid-derived CCN3 resulted in increases in genes involved in lipid synthesis and oxidized lipoprotein uptake. In fact, CD36, a well-known transmembrane protein involved in oxidized LDL uptake into macrophages, was upregulated in both of our models of atherosclerosis and NASH. Loss of myeloid-derived CCN3 also increased expression of transcription factors involved in the ER stress response (Fig. 5) . Recent work has highlighted the effects of CCN proteins on induction of the unfolded protein response (UPR) due to ER stress (Borkham-Kamphorst et al. 2016) . Borkham-Kamphorst et al. suggest that elevated levels of CCNs aid in tissue repair after hepatic injury, but there is a plateau where additional CCN protein beyond that results in increased apoptosis. CCN3 is of special interest because it has no endogenous expression in hepatocytes (BorkhamKamphorst et al. 2012a, b; and its targeted expression has shown therapeutic properties via inhibition of CCN2 gene expression (Borkham-Kamphorst et al. 2012b , van Roeyen et al. 2012 , Abd El Kader et al. 2013 ). Our results suggest that myeloid-derived CCN3 may play a protective role in NASH, in part, by limiting ER stress and ROS production, but also by affecting the UPR and CCN2 gene expression. Further experiments to test this will be of great interest. Fig. 5 Myeloid-derived CCN3 protects the liver from nonalcoholic steatohepatitis. On mice fed a methionine-and choline-deficient diet to induce NASH, loss of myeloid-derived CCN3 enhances the accumulation of hepatic lipid, in part, by regulation of key factors involved in lipid synthesis, oxidation and uptake. Additionally, there is increased inflammatory cell infiltration into the tissue as well as increased ER stress and ROS generation within these cells, leading to subsequent hepatocytic death
